Table 3.
Comparison of patients with no/mild AKI and those with severe AKI.
| Laboratory measure | Median (min, max) | P value | |
|---|---|---|---|
| No/Mild AKI (Stage 0,1) n=3 |
Severe AKI (Stage 2,3) n=17 |
||
| Uric acid (mg/dL) | |||
| 6 h pre CKRT | 3.70 (2.3, 9.0) | 3.90 (0.2, 29.7) | 0.723 |
| 12 h pre CKRT | 2.40 (1.1, 7.7) | 5.00 (0.9, 17.7) | 0.3643 |
| Phosphorus (mg/dL) | |||
| 6 h pre CKRT | 8.20 (7.3, 8.9) | 10.65 (3.8, 14.9) | 0.1785 |
| 12 h pre CKRT | 6.40 (5.1,7.1) | 10.50 (5.8, 12.4) | 0.0375 |
| Calcium (mg/dL) | |||
| 6 h pre CKRT | 7.30 (6.6, 7.5) | 6.65 (4.9, 9.7) | 0.3199 |
| 12 h pre CKRT | 7.40 (7.3, 7.5) | 7.10 (5.6, 9.0) | 0.2964 |
| LDH 1 d pre CKRT (U/L) | 2303.00 (2147.0, 2790.0) | 2340.50 (351.0, 10065.0) | 0.9577 |
| Duration of hospital stay (d) | 16.00 (9.0, 21.0) | 12.00 (7.0, 42.0) | 0.4825 |
| Duration of ICU stay (d) | 7.00 (4.0, 8.0) | 6.00 (3.0, 36.0) | 0.8491 |
AKI, acute kidney injury; CKRT, continuous kidney replacement therapy; LDH, lactate dehydrogenase; ICU, intensive care unit.